Raymond James Financial Inc. Invests $888,000 in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ)

Raymond James Financial Inc. acquired a new stake in shares of Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 41,261 shares of the company’s stock, valued at approximately $888,000. Raymond James Financial Inc. owned approximately 2.33% of Invesco Nasdaq Biotechnology ETF as of its most recent filing with the Securities & Exchange Commission.

Separately, Strategic Financial Concepts LLC acquired a new stake in shares of Invesco Nasdaq Biotechnology ETF during the 4th quarter valued at $1,699,000.

Invesco Nasdaq Biotechnology ETF Trading Down 5.5 %

NASDAQ IBBQ opened at $19.45 on Friday. Invesco Nasdaq Biotechnology ETF has a 1-year low of $19.45 and a 1-year high of $24.84. The firm’s fifty day simple moving average is $22.23 and its 200-day simple moving average is $22.67. The company has a market capitalization of $34.43 million, a PE ratio of 26.48 and a beta of 0.61.

Invesco Nasdaq Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, March 28th. Shareholders of record on Monday, March 24th were given a $0.0402 dividend. The ex-dividend date of this dividend was Monday, March 24th.

Invesco Nasdaq Biotechnology ETF Company Profile

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.